TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: binary restenosis
Endpoint domain: Adverse events/effects
Primary endpoint: Competency in peg transfer task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Competency in laparoscopic suturing task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Workload due to distraction
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Complete alcohol cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reactive balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: processing speed decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: visuospatial ability decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: verbal recall improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: neurocognitive performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: educational attainment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: emotional outcomes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in central thickness (CT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hyperemic myocardial blood flow (MBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time spent in 3.9‐10 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Resourcefulness scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: reduced use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subsequent mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: good outcome (CPC 1-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative ecchymosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: social-emotional competence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: qCSA size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dynamic knee extensor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: isometric knee extensor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Falls per 1,000 occupied bed days
Endpoint domain: Adverse events/effects
Primary endpoint: Number of CSBMs/week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Visual analog scale pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient Assessment of Constipation Quality of Life total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: perceived risk of CCA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived severity of CCA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: correct behaviors of CCA prevention
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time/day with CO2 concentration > 800 ppm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative norepinephrine doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: P/F ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPD decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean VAS score increase
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Resolution of peri-implantitis lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported seat-belt use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Major adverse outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Unintentional discrepancies in the transfer of care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of recruitment and retention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prevention of ACLF development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: reductions in hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge scores for pressure injury assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laboratory and clinical pressure injury assessment skill scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct staging percentages during clinical practice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of TA-TMA
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in vaginal health index (VHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in sexual function (FSFI scores)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 5-year composite outcome of death, myocardial infarction, and unplanned revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Learning score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: everyday executive dysfunction
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: PaO2/FiO2 (P/F) ratio post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Median days of hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of mechanically ventilated patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: MetS number of factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medicine use score
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Phenylephrine dose required to maintain normotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: BODI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity during jaw movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary irritation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: number of 20-m shuttle runs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acceptable hearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contamination of body regions pre-doffing of PPE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of malaria prevention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recall of malaria prevention messages
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Use of insecticide-treated nets (ITNs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Gd-IgA1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Stability of renal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: insertional pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of text message program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usefulness of text message program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: total POSAS score of tissue adhesive
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: overall number of errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dual item accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: single item accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: compassion satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reoperation incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in NPSI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average time of osseous fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Targeting of DLPFC brain regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of preoperative delirium
Endpoint domain: Adverse events/effects
Primary endpoint: increased pulmonary outcome score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: radiographically confirmed pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Expression of inflammatory molecules (IL-1β, IL-18, NLRP3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from 'full code' to 'do not resuscitate'
Endpoint domain: Mortality/survival
Primary endpoint: secondary resectability rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of danger signs in pregnancy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of correct management of childhood diarrhoea
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FMD variation from baseline to 3-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: FIA (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Complete disintegration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean session time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: American College of Rheumatology 20% response rates at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's eating habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cognitive function composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Language function composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conners' Teachers scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: False-negative readings in GLP-1R imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional outcomes 3 months after endovascular treatment for stroke
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Secondary stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital re-admissions incidence
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: ED presentation incidence
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Combined re-admission and ED presentation incidence
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Treatment-seeking intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Depression Stigma Scale (DSS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: percentage of healthy food purchases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CVD or HHF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Analgesic plasma concentration ≥ 0.5 ng/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rapid-onset analgesia within 10 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal PIEB bolus volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention rates of restorations after 18 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minor marginal discoloration at 18 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unintended pregnancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of newborns calm after first bath
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of newborns having bath at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean incubation time before first bath
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stat anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in average level of lipoprotein resistance to oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Primary outcome in the aorta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: median percentage of talar and total talonavicular joint surface area prepared
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Symptoms burden
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Satisfaction with quality of care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: diagnostic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: clinical response at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical remission at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of subclinical atheromatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Levels of omega 6 (n‐6) fatty acids compared to omega 3 (n‐3) fatty acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Levels of linoleic acid (LA) to docosahexaenoic acid (DHA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Levels of n‐3 DHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Oral candidiasis episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Levels of IL‐1β
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Entomological inoculation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mosquito mortality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total recognition accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in RVEF after 6 months of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pulse Pressure (PP) decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sodium intake decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent enrolment target achievement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Attendance target achievement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: baseline autonomy scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Transcultural self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in breast-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in extracellular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Survival (OS) endpoints
Endpoint domain: Mortality/survival
Primary endpoint: Progression-Free Survival (PRS) endpoints
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative AHI reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of inflammatory complications
Endpoint domain: Adverse events/effects
Primary endpoint: white blood cells count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: In-hospital MACCE rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of life (QOL) metrics
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ICA flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of VAP
Endpoint domain: Mortality/survival
Primary endpoint: Change in the number of aberrant morae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voice Handicap Index (VHI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Waterpipe smoking cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma vardenafil concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain reduction from needle insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full symptom resolution at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Medical Expenditure (TME)
Endpoint domain: Resource use
Primary endpoint: Improvement in mothers' core ADHD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in mothers' emotion regulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in parenting measures (positive parenting, inconsistent discipline, corporal punishment)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: prevalence of transplantation wait-listing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: prevalence of living donor transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: prevalence of peritoneal dialysis use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average discomfort scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MAS scores of upper and lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MBI scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ≥ 40% ulcer-area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histological persistence of Eosinophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IHS4-response maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gingival papilla increasement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive function improvement (CVLT-II z score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in MDS‐UPDRS part III scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with a 25% or more reduction in ADHD‐RS‐V scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean ADHD‐RS‐V score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean CGI‐EI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of IS diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: macular hole closing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative best‐corrected visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: macular morphology recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in MFVDS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (Dindo-Clavien III-V)
Endpoint domain: Adverse events/effects
Primary endpoint: lipid grade improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term functional status improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: New morbidity development
Endpoint domain: Adverse events/effects
Primary endpoint: lags of accommodation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atrial arrhythmia recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two-year overall survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Grade 3-4 acute adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical improvement in central nervous system and neuromuscular symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes